Cancer Control

Cancer Control

癌症控制

  • 4区 中科院分区
  • Q3 JCR分区

期刊简介

《Cancer Control》是由SAGE Publications Inc.出版社于1994年创办的英文国际期刊(ISSN: 1073-2748,E-ISSN: 1526-2359),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为ONCOLOGY。作为SCIE收录期刊(JCR分区 Q3,中科院 4区),本刊采用OA开放获取模式(OA占比1%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比86.82%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在129篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Cancer Control审稿周期约为 12周,或约稿 。该刊近年未被列入国际预警名单,年发文量约129篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 129 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
ONCOLOGY 肿瘤学
4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
ONCOLOGY 肿瘤学
4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q3 183 / 322

43.3%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q3 201 / 322

37.73%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:3.8 SJR:0.698 SNIP:0.692
学科类别 分区 排名 百分位
大类:Medicine 小类:Hematology Q3 72 / 137

47%

大类:Medicine 小类:Oncology Q3 220 / 404

45%

期刊发文

  • Research Progress of Tumor Microenvironment Targeted Therapy for Clear Cell Renal Cell Carcinoma

    Author: Huang, Yongqiang; Sun, Hong; Guo, Pu

    Journal: CANCER CONTROL. 2023; Vol. 30, Issue , pp. -. DOI: 10.1177/10732748231155700

  • Survival Outcomes of Patients with International Federation of Gynecology and Obstetrics Stage IV Ovarian Cancer: Cytoreduction Still Matters

    Author: Xiao, Yao; Linghu, Hua

    Journal: CANCER CONTROL. 2023; Vol. 30, Issue , pp. -. DOI: 10.1177/10732748231159778

  • Mammographic Density Reduction is Associated to the Prognosis in Asian Breast Cancer Patients Receiving Hormone Therapy

    Author: Shia, Wei-Chung; Lin, Li-Sheng; Wu, Hwa-Koon; Chen, Chih-Jung; Chen, Dar-Ren

    Journal: CANCER CONTROL. 2023; Vol. 30, Issue , pp. -. DOI: 10.1177/10732748231160991

  • Blocking CD47-SIRP alpha Signal Axis as Promising Immunotherapy in Ovarian Cancer

    Author: Luo, Xukai; Shen, Yini; Huang, Wu; Bao, Yiting; Mo, Jiahang; Yao, Liangqing; Yuan, Lei

    Journal: CANCER CONTROL. 2023; Vol. 30, Issue , pp. -. DOI: 10.1177/10732748231159706

  • Differentiation of Bone Metastasis in Elderly Patients With Lung Adenocarcinoma Using Multiple Machine Learning Algorithms

    Author: Zhou, Cheng-Mao; Wang, Ying; Xue, Qiong; Zhu, Yu

    Journal: CANCER CONTROL. 2023; Vol. 30, Issue , pp. -. DOI: 10.1177/10732748231167958

  • The Combination of JAK2V617F Allele Burden and WT1 Expression can Be Helpful in Distinguishing the Subtype of MPN Patients

    Author: Wu, Sanyun; Luo, Ping; Rouzi, Tuerxunayi; Yu, Yalan; Xiong, Bei; Wang, Yingying; Zuo, Xuelan

    Journal: CANCER CONTROL. 2023; Vol. 30, Issue , pp. -. DOI: 10.1177/10732748231163648

  • Immune-Related Genes' Prognostic, Therapeutic and Diagnostic Value in Ovarian Cancer Immune-Related Gene Biomarker in Ovarian Cancer

    Author: Ding, Bo; Yan, Wenjing; Shen, Siyuan; Meng, Dan; Chen, Xue; Wang, Shizhi; Shen, Yang

    Journal: CANCER CONTROL. 2023; Vol. 30, Issue , pp. -. DOI: 10.1177/10732748231168756

  • Weight Loss During Neoadjuvant Therapy Is Associated With Poor Response Among the Patients With Gastrointestinal Cancer: A Propensity Score Matching Analysis

    Author: Bu, Zhaoting; Jiang, Yuting; Luo, Shanshan; He, Xinxin; Qin, Haiquan; Tang, Weizhong

    Journal: CANCER CONTROL. 2023; Vol. 30, Issue , pp. -. DOI: 10.1177/10732748231164016